Latest Market News

Anson Resources has pushed forward the Definitive Feasibility Study for its Green River Lithium Project, targeting completion in January 2027 after a key engineering meeting in Las Vegas.

New Zealand Rural Land Company faces uncertainty as Kiwi Crunch Farms, a tenant accounting for nearly 6% of rental income, enters receivership. Additional leases tied to the same owner add to risk, prompting suspension of earnings guidance.

White Energy confirms ASX listing rules exemption for its proposed US metallurgical and Surat Basin coal assets acquisition, advancing due diligence and capital raising plans.

Energy Resources of Australia faces extended uncertainty as Zentree Investments lodges an appeal against Rio Tinto’s compulsory acquisition, prolonging ERA’s delisting and share suspension.

Qoria Limited marked a turning point in FY25, delivering 25% growth in Annual Recurring Revenue and a 684% jump in underlying EBITDA, setting sights on 20% EBITDA margin in FY26 amid global digital safety expansion.

Qoria Limited’s acquisition by Aura Consolidated Group has become legally effective following Federal Court approval, with Qoria shares suspended and Aura CHESS Depositary Interests set for issuance in mid-July.

Qube Holdings' acquisition by Rubik Australia is now legally effective following Supreme Court approval, with trading suspension imminent. The company has declared a fully franked special dividend of $0.3465 per share, payable mid-July, ahead of the scheme implementation in August.

Larvotto Resources rejects Austral Resources' non-binding bid for Hammer Metals, underscoring its binding scheme and operational strengths including imminent production at Hillgrove.

Proteomics International has won a key US patent for its PromarkerEndo blood test, bolstering its commercial foothold in the world’s largest healthcare market. The patented technology offers a non-invasive, accurate diagnosis of endometriosis, a condition that currently takes years to detect.

Australian Rare Earths (ASX: AR3) has discovered a promising niobium-rare earth carbonatite system at its Overland Project, marked by significant mineralisation in a single drill hole and linked to a large magnetic anomaly.

Island Pharmaceuticals is progressing its broad-spectrum antiviral Galidesivir amid a severe Ebola outbreak, securing government approvals in Uganda and outlining a dual clinical and regulatory development pathway targeting multiple deadly filoviruses.

IperionX has secured approximately US$50 million through a public offering of American Depositary Shares, targeting the scale-up of its titanium production and expansion of key US facilities.